Published in Dig Surg on June 24, 2008
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol (2012) 2.38
Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index. World J Surg (2012) 1.14
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review. Indian J Surg Oncol (2011) 1.13
The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys (2010) 1.05
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford) (2010) 1.02
iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance. Br J Cancer (2013) 0.99
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma. BMC Surg (2013) 0.99
Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer. Br J Cancer (2010) 0.98
Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol (2015) 0.96
Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? J Gastrointest Surg (2009) 0.87
Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us? J Gastrointest Oncol (2014) 0.86
Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. Mol Cancer (2014) 0.85
Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer. Med Oncol (2012) 0.84
Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma. HPB (Oxford) (2016) 0.82
Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol (2012) 0.80
53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. BMC Cancer (2013) 0.79
Lymph node retrieval in pancreaticoduodenectomy specimens: does educating the pathologist matter? HPB (Oxford) (2013) 0.77
Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. Biomed Rep (2014) 0.77
Prognostic value of the lymph node ratio after resection of periampullary carcinomas. HPB (Oxford) (2012) 0.76
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. J Gastrointest Oncol (2016) 0.75
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. J Gastrointest Oncol (2016) 0.75
Pancreatic mucinous cystadenoma with serum CA 19-9 over 1,000,000 U/mL: a case report and review of the literature. World J Surg Oncol (2015) 0.75
Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer. Clin Exp Med (2015) 0.75
What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ (1999) 13.99
Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev (2007) 10.34
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg (1995) 3.42
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut (2005) 3.32
Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J (2001) 3.22
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin. Nature (1987) 2.96
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Management of bile duct stones in the era of laparoscopic cholecystectomy. Br J Surg (1994) 2.91
Head-up tilt: a useful test for investigating unexplained syncope. Lancet (1986) 2.67
Randomised controlled trial of physiological and ventricular pacing. Br Heart J (1983) 2.66
Successes, failures, early complications and their management following endoscopic sphincterotomy: results in 394 consecutive patients from a single centre. Br J Surg (1985) 2.66
Inflammatory mediators in acute pancreatitis. J Pathol (2000) 2.66
Vasovagal reactions may occur after orthotopic heart transplantation. J Am Coll Cardiol (1993) 2.63
Colon perforation during colonoscopy: surgical versus conservative management. Br J Surg (1991) 2.58
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol (1991) 2.53
Prospective randomised study of preoperative endoscopic sphincterotomy versus surgery alone for common bile duct stones. Br Med J (Clin Res Ed) (1987) 2.48
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia (2007) 2.40
Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A (2000) 2.34
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer (2005) 2.32
Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery. Gut (1988) 2.22
Venous graft surgery in treatment of coronary heart disease. Br Med J (1972) 2.21
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat (2008) 2.19
Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg (2005) 2.16
Report of a study group on ablate and pace therapy for paroxysmal atrial fibrillation. Barcelona Discussion Group. Working Group on Arrhythmias of the European Society of Cardiology. Europace (1999) 2.08
Early and late complications after pancreatic necrosectomy. Surgery (2005) 2.03
Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res (2000) 1.99
PALB2 mutations in European familial pancreatic cancer families. Clin Genet (2010) 1.99
Carotid sinus syncope treated by pacing. Analysis of persistent symptoms and role of atrioventricular sequential pacing. Br Heart J (1982) 1.98
Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther (1993) 1.96
Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol (1996) 1.92
Current standards of surgery for pancreatic cancer. Br J Surg (2004) 1.92
Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder. BMJ (1998) 1.92
Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation (1986) 1.88
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia (2007) 1.79
Heart-block following acute myocardial infarction. Treatment with demand and fixed-rate pacemakers. Lancet (1968) 1.77
The management of common bile duct calculi by endoscopic sphincterotomy in patients with gallbladders in situ. Br J Surg (1984) 1.76
Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: a prospective study. Br J Surg (1989) 1.75
Acute pancreatitis: the substantial human and financial costs. Gut (1998) 1.74
Pacemakers and defibrillators: anaesthetic implications. Br J Anaesth (2004) 1.71
Accuracy in ECG lead placement among technicians, nurses, general physicians and cardiologists. Int J Clin Pract (2007) 1.71
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer (2009) 1.69
The natural history of sick sinus syndrome. Pacing Clin Electrophysiol (1986) 1.65
Serial computed tomography scanning in acute pancreatitis: a prospective study. Gut (1989) 1.63
Systematic review of the use of honey as a wound dressing. BMC Complement Altern Med (2001) 1.63
Evaluation of herniography in the diagnosis of an occult abdominal wall hernia in symptomatic adults. Br J Surg (1990) 1.60
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer (2007) 1.58
Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res (1995) 1.57
Pacemaker syndrome. Br Med J (Clin Res Ed) (1986) 1.55
Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis. Gut (1992) 1.53
Chemical treatment of stones in the biliary tree. Br J Surg (1986) 1.53
Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg (1986) 1.53
The conduction system in acute myocardial infarction complicated by heart block. Circulation (1968) 1.53
Cholecystectomy-related bile duct and vasculobiliary injuries. Br J Surg (2012) 1.52
(131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndrome. Eur J Surg Oncol (2001) 1.51
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
Pacemaker lead related tricuspid stenosis: a report of two cases. Heart (2000) 1.50
Safety of coronary arteriography. Br Heart J (1973) 1.50
Relaxation therapies for the management of primary hypertension in adults: a Cochrane review. J Hum Hypertens (2008) 1.50
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses. Br J Cancer (2008) 1.50
Permanent pacemaker implantation via the femoral vein: an alternative in cases with contraindications to the pectoral approach. Europace (2001) 1.48
Pacemaker syndrome: an iatrogenic condition. Br Heart J (1992) 1.48
Tilting towards a diagnosis in recurrent unexplained syncope. Lancet (1989) 1.47
A prospective study of ERCP and endoscopic sphincterotomy in the diagnosis and treatment of gallstone acute pancreatitis. A rational and safe approach to management. Arch Surg (1986) 1.46
Respiratory changes in vasovagal syncope. J Cardiovasc Electrophysiol (2000) 1.46
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer (2011) 1.45
Surface geochemistry of the clay minerals. Proc Natl Acad Sci U S A (1999) 1.45
Gastrointestinal zygomycosis: two case reports. Histopathology (2004) 1.45
'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace (2000) 1.43
Adjuvant therapy in pancreatic cancer: historical and current perspectives. Ann Oncol (2003) 1.42
Carotid sinus syncope. Int J Cardiol (1984) 1.41
Apical node metastasis independently predicts poor survival in Dukes C colorectal cancer. Colorectal Dis (2011) 1.40
How and when to investigate syncope. Br J Hosp Med (1991) 1.40
Research in higher surgical training--the West Midlands view. Ann R Coll Surg Engl (1993) 1.40
Method of preparing emergency medicine residents for giving legal depositions. J Am Osteopath Assoc (1999) 1.39
Complications of pancreatic cancer resection. Dig Surg (2002) 1.38
The NASPE/BPEG generic pacemaker code for antibradyarrhythmia and adaptive-rate pacing and antitachyarrhythmia devices. Pacing Clin Electrophysiol (1987) 1.37
Calcium signalling and pancreatic cell death: apoptosis or necrosis? Cell Death Differ (2007) 1.35